CME vs LPLA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 02, 2026
CME
54.6
AI Score
VS
LPLA Wins
LPLA
75.9
AI Score
Investment Advisor Scores
LPLA
76score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CME | LPLA | Winner |
|---|---|---|---|
| Revenue | 3.59B | 10.13B | LPLA |
| Net Income | 2.20B | 735.66M | CME |
| Net Margin | 61.2% | 7.3% | CME |
| ROE | 8.3% | 12.8% | LPLA |
| ROA | 1.1% | 3.7% | LPLA |
| Total Assets | 194.68B | 19.79B | CME |
| Cash | 2.14B | 1.28B | CME |
| Free Cash Flow | 2.16B | 327.14M | CME |
Relative Price Performance (Last 90 Days)
CME 1M: -5.3%
· 3M: +12.1%
LPLA 1M: -10.9%
· 3M: +3.8%
Current Technical Phase
CME
NeutralHold
Mixed signals - no dominant trend phase, RSI 42
LPLA
NeutralHold
Mixed signals - no dominant trend phase, RSI 41
Fundamentals Snapshot
| Metric | CME | LPLA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 20.4 | 10.6 |
| Trailing P/E | 22.2 | 24.5 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.4% |
| Gross Margin | 1.0% | 0.3% |
| Operating Margin | 0.7% | 0.1% |
| EPS | 11.93 | 12.73 |
| Dividend Yield | 0.02% | 0.00% |
Frequently Asked Questions
Based on our detailed analysis, LPLA is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.